Monopar Therapeutics (MNPR) Prepaid Assets (2016 - 2025)

Monopar Therapeutics has disclosed Prepaid Assets across 10 years of filings, most recently posting $63745.0 for Q4 2025.

• Prepaid Assets for Q4 2025 came in at $63745.0, down 19.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $63745.0 (down 19.18% YoY), and the FY2025 annual result was $63745.0, down 19.18% from the prior year.
• Prepaid Assets came in at $63745.0 for Q4 2025 at Monopar Therapeutics, down from $414825.0 in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $523556.0 in Q1 2025 to a low of $45982.0 in Q4 2022.
• The 5-year median for Prepaid Assets is $106809.5 (2021), against an average of $159167.5.
• Across the five-year window, Prepaid Assets slumped 78.88% in 2022 and soared 736.85% in 2025, its largest moves.
• Monopar Therapeutics' Prepaid Assets stood at $217745.0 in 2021, then plunged by 78.88% to $45982.0 in 2022, then surged by 44.48% to $66433.0 in 2023, then gained by 18.72% to $78869.0 in 2024, then dropped by 19.18% to $63745.0 in 2025.
• The last three Prepaid Assets figures came in at $63745.0 (Q4 2025), $414825.0 (Q3 2025), and $497294.0 (Q2 2025), per Business Quant data.